Find the latest pharmaceutical market place for formulations enquiry about Lanreotide Acetate on PharmaCompass.com.

Serbia-big Flag

Various Finished Dosage Formulations needed in Serbia [ENA13764]

A company focused in marketing and distribution of prescription, OTC, food supplement and medical device is looking for suppliers of Various Finished Dosage Formulations for hospital & tender purposes. The suppliers must support this enquiry with EUGMP and eCTD dossier.
1. Filgrastim (300 mcg/ 0.5 ml) Solution for Injections or Infusions in Prefilled Syringes. The required quantity in three years is 4,520 units.
2. Filgrastim (480 mcg/ 0.5 ml) Solution for Injections or Infusions in Prefilled Syringes. The required quantity in three years is 19,320 units.
3. Methylprednisolone (40 mg/ ml) Injections/ Powder and Solvent for Solution for Injections or Infusions. The required quantity in three years is 1.8 million units.
4. Lanreotide (120 mg/ ml) Solution for Injections. The required quantity in three years is 1,400 units.

Reply

26 May 2022

Various Finished Dosage Formulations needed in Jordan [ENA11396]

A company that deals in the distribution of various pharmaceutical products is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with EU dossiers for each.
1. Adalimumab (40 mg/ 0.8 ml) Pre-filled Syringes. The required quantity is 40,000 units.
2. Etanercept (25 mg & 50 mg) Pre-filled Syringes. The required quantity is 25,000 units & 250,000 units respectively.
3. Lanreotide Acetate (90 mg & 120 mg) Pre-filled Syringes. The required quantity is 5,000 units & 4,000 units respectively.
4. Filgrastim (300 mcg) Pre-filled Syringes. The required quantity is 150,000 units.
5. Goserelin Acetate (3.6 mg) Implant. The required quantity is 62,000 units.
6. Ranibizumab (10 mg/ ml) Pre-filled Syringes. The required quantity is 12,750 units.

Reply

15 Sep 2021

Various Finished Dosage Formulations needed in Iran [ENA11303]

A privately owned healthcare and pharmaceutical company focused on the development and commercialization of a portfolio of products and services within the areas of aesthetics, dermatology, medical food supplement and tech transfer is looking for suppliers of Various Finished Dosage Formulations for commercial purpose. The suppliers must support this enquiry with CTD Dossiers.
1. Cycloserine (250 mg) Capsules
2. Dalteparin Sodium (25000 IU/ ml) Injections
3. Dapagliflozin Sodium (25 mg) Capsules
4. Dapagliflozin (5 mg) Tablets
5. Didanosine (200 mg) Capsules
6. Droperidol (1.25 mg/ ml) Injections
7. Eprosartan Mesylate (600 mg) Tablets
8. Goserelin Acetate (10.8 mg) Implants
9. Lanreotide Acetate (120 mg & 60 mg) Injections
10. Prothionamide (125 mg) Tablets

Reply

04 Sep 2021

Tender// Various Finished Dosage Formulations needed in Norway [ENA09768]

The Norwegian Hospital Procurement Trust is looking for supplies of Various Finished Dosage Formulations. The deadline is 16-March-2021.
1. Pegvisomant (25 mg, 30 mg, 15 mg, 20 mg and 10 mg) Powder and Solvent for Solution for Injection. The required quantity is 33 units, 64 units, 70 units, 108 units and 118 units respectively.
2. Octreotide (10 mg, 20 mg and 30 mg) Powder and Liquid for Depot Injection. The required quantity is 80 units, 252 units and 1328 units respectively.
3. Octreotide (10 mg, 20 mg and 30 mg) Powder and Solvent for Solution for Injection. The required quantity is 486 units, 1060 units and 2998 units respectively.
4. Octreotide (50 mcg/ ml, 200 mcg/ ml and 100 mcg/ ml) Injection/ Infusion Solution. The required quantity is 686 units, 2812 units and 3081 units respectively.
5. Lanreotide (60 mg/ spr, 90 mg/ spr and 120 mg/ spr) Solution for Injection. The required quantity is 27 units, 321 units and 4950 units respectively.
6. Pasireotide (10 mg, 20 mg, 60 mg and 40 mg) Powder and Solvent for Solution for Injection. The required quantity is 6 units, 10 units, 20 units and 112 units respectively.
7. Pasireotide (0.6 mg/ ml) Solution for Injection. The required quantity is 7 units.

Reply

19 Feb 2021

PuertoRico Flag

Various Finished Dosage Formulations needed in Puerto Rico [ENA09492]

An international pharmaceutical company that focuses on the commercialization of therapies is looking for suppliers of Various Finished Dosage Formulations for commercial manufacturing purposes. The final market is India.
1. Isoproterenol (0.2 mg/ ml concentration in 1 ml and 5 ml liquid vials) for Injection
2. Palonosetron HCl (0.25 mg in 5 ml liquid vial) for Injection
3. Nelarabine (5 mg/ ml concentration of 250 mg in 5 ml liquid vial) for Injection
4. Lanreotide (120 mg in 0.5 ml Prefilled Syringe) for Injection
5. Zoledronic acid (0.8 mg/ ml concentration of 5 mg in 100 ml liquid vial) for Injection

Reply

14 Jan 2021